$1.03
0.98%
Nasdaq, Sep 17, 04:00 pm EDT. Closed.
ISIN
US0310941051
Symbol
AMST

Amesite Operating Co Stock price

$1.03
+0.07 7.28% 1M
-0.73 41.48% 6M
-0.86 45.50% YTD
-2.11 67.20% 1Y
-1.48 58.96% 3Y
-20.57 95.23% 5Y
-61.61 98.36% 10Y
-61.61 98.36% 20Y
Nasdaq, Closing price Thu, Sep 17 2026
+0.01 0.98%
ISIN
US0310941051
Symbol
AMST

Is Amesite Operating Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
$6.7m
Enterprise Value
$6.0m
Net debt
positive
Cash
$640.0k
Shares outstanding
4.7m
Valuation (TTM | estimate)
P/E
negative
P/S
19.6 | -
EV/Sales
17.8 | -
EV/FCF
negative
P/B
5.1
Financial Health
Equity Ratio
88.4%
Return on Equity
-132.1%
ROCE
-233.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$340.0k | -
EBITDA
$-2.8m
EBIT
$-3.0m
Net Income
$-3.0m
Free Cash Flow
$-2.2m
Growth (TTM | estimate)
Revenue
325.0% | -
EBITDA
24.2%
EBIT
23.2%
Net Income
23.0%
Free Cash Flow
28.6%
Margin
Gross
-
EBITDA
-807.7%
EBIT
-890.5%
Net
-872.0%
Free Cash Flow
-649.8%
More
EPS
$-0.7
FCF per Share
$-0.5
Short interest
0.3%
Employees
6
Rev per Employee
$20.0k

Amesite Operating Co Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Amesite Operating Co forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Amesite Operating Co forecast:

Buy
86%
Hold
14%

Amesite Operating Co Events

Upcoming Event
SEP
28
Q4 2026 Earnings Call
in 11 days

Financial data from Amesite Operating Co

Mar '26
+/-
%
0.34 0.34
325% 325%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 3.01 3.01
19% 19%
885%
- Research and Development Expense - -
-
-
-2.76 -2.76
24% 24%
-812%
- Depreciation and Amortization 0.28 0.28
10% 10%
82%
EBIT (Operating Income) EBIT -3.04 -3.04
23% 23%
-894%
Net Profit -2.98 -2.98
23% 23%
-876%

In millions USD.

Don't miss a Thing! We will send you all news about Amesite Operating Co directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Amesite Operating Co Stock News

Neutral
GlobeNewsWire
4 months ago
Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care
Neutral
GlobeNewsWire
5 months ago
$2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrants $2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrants
Neutral
GlobeNewsWire
5 months ago
DETROIT, April 28, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D, its Chairman and CEO, and George Parmer, a member of its board of directors, for the purchase and sale ...
More Amesite Operating Co News

Company Profile

Amesite, Inc. is a development stage artificial intelligence software company. The company is headquartered in Detroit, MI.

Head office United States
CEO Dr. Sastry
Employees 6
Founded 2017
Website amesite.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today